CBD and Cannabis terpenes outperform leading COVID-19 treatment in early trial
Many Israeli companies and Universities have been exploring the role CBD and cannabis terpenes could play in fighting the coronavirus.
The University of Nebraska and the Texas Biomedical Research Institute first flagged the possibility in a peer reviewed article. They pointed out that CBD may be helpful for fighting the cytokine storms in Covid-19.
Cytokines are proteins in the body that play an important role in our immune response - increasing inflammation in reaction to infections. Researchers have reported that CBD’s anti-inflammatory and anti-viral properties might provide key resistance against the coronavirus and thus potentially, end the cytokine storms.
As new studies are tested on CBD for COVID-19 patient relief, an Aiken hemp farm owner hopes her product can help. A local store selling CBD processed from her farm has seen the increase in consumer demand.— WJBF (@WJBF) July 22, 2020
Public health officials have lamented that the rush to identify a reliable COVID-19 treatment has led to “desperation science,” marked by maverick experimentation and faulty research, early trial results indicate otherwise.
It has to do with the cytokine storm caused by COVID-19, which results in an inflammation hurricane in the respiratory system. A person’s immune system can overreact and the lungs can shut down in severe cases. The few therapeutic treatments that have worked, according to researchers in this month’s issue of Brain, Behavior, and Immunity, have caused adverse side effects, including pancreatitis and increased risk of heart disease.
This is crucial in fighting off infections, but sometimes in severe infections the body goes too far, and releases too many cytokines into the blood too quickly - this is a cytokine storm, and it can be really dangerous, causing high fever, too much inflammation (redness and swelling), severe fatigue, nausea, difficulty breathing and in some cases death due to organ failure.
More research is much needed. scientists can now turn to a natural solution with very little to no adverse side effects. That, in itself, is something to be optimistic about in the very near future but research testing cannabis on humans is notoriously difficult to get approved.